Personalized NK Cell Therapy in CBT

This study is testing whether a personalized natural killer (NK) cell therapy — using immune cells from a cord blood transplant donor — can help patients with blood cancers recover better after a cord blood stem cell transplant. **You may be eligible if...** - You have a blood cancer such as acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), chronic myelogenous leukemia (CML), or certain types of lymphoma - Your cancer has not responded to standard treatment, has returned after treatment, or you are considered high risk for relapse - You are scheduled to receive a cord blood stem cell transplant - You are in adequate overall health to tolerate the transplant **You may NOT be eligible if...** - Your heart, liver, kidneys, or lungs are not functioning well enough - You have an active, uncontrolled infection - You are pregnant or breastfeeding - You have other serious medical conditions that make a transplant too risky Talk to your doctor to see if this trial is right for you.